Ensign Peak Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
|
|||||
|
2025
Q1 | $1.17M | Sell |
|
|||||
|
2024
Q4 | $1.81M | Hold |
|
|||||
|
2024
Q3 | $1.48M | Hold |
|
|||||
|
2024
Q2 | $1.34M | Hold |
|
|||||
|
2024
Q1 | $1.16M | Hold |
|
|||||
|
2023
Q4 | $858K | Hold |
|
|||||
|
2023
Q3 | $838K | Hold |
|
|||||
|
2023
Q2 | $619K | Hold |
|
|||||
|
2023
Q1 | $727K | Buy |
|
|||||
|
2022
Q4 | $606K | Buy |
|
|||||
|
2022
Q3 | $439K | Buy |
|
|||||
|
2022
Q2 | $356K | Buy |
|
|||||
|
2022
Q1 | $431K | Hold |
|
|||||
|
2021
Q4 | $367K | Buy |
|
|||||
|
2021
Q3 | $432K | Hold |
|
|||||
|
2021
Q2 | $439K | Buy |
|
|||||
|
2021
Q1 | $425K | Hold |
|
|||||
|
2020
Q4 | $356K | Hold |
|
|||||
|
2020
Q3 | $332K | Buy |
|